China SXT Pharmaceuticals, Inc.
SXTC
$0.09
-$0.01-5.62%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.87M | -6.09M | -3.30M | 1.25M | 5.80M |
| Total Depreciation and Amortization | 46.00K | 64.20K | 82.40K | 125.70K | 169.00K |
| Total Amortization of Deferred Charges | 432.40K | 476.60K | 520.80K | 344.60K | 168.40K |
| Total Other Non-Cash Items | 6.87M | 4.10M | 1.33M | -3.03M | -7.39M |
| Change in Net Operating Assets | -1.22M | -1.09M | -971.80K | -1.21M | -1.44M |
| Cash from Operations | -2.74M | -2.54M | -2.35M | -2.53M | -2.71M |
| Capital Expenditure | -2.00K | -2.00K | -2.00K | -4.50K | -7.00K |
| Sale of Property, Plant, and Equipment | 25.00K | 45.30K | 65.60K | 53.10K | 40.60K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -924.60K | -462.30K | -- | 6.90K | 13.80K |
| Cash from Investing | -901.60K | -419.00K | 63.60K | 55.50K | 47.40K |
| Total Debt Issued | 616.40K | 4.15M | 7.69M | 8.22M | 8.76M |
| Total Debt Repaid | -1.96M | -1.94M | -1.92M | -710.50K | 497.00K |
| Issuance of Common Stock | 7.94M | 5.35M | 2.76M | 1.38M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -67.60K | -101.40K | -135.20K | -156.60K | -178.00K |
| Cash from Financing | 6.53M | 7.47M | 8.40M | 8.74M | 9.07M |
| Foreign Exchange rate Adjustments | -206.00K | -135.60K | -65.20K | 283.20K | 631.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.68M | 4.37M | 6.05M | 6.55M | 7.05M |